How Much Did ViiMed Raise?
Funding & Key Investors

ViiMed, a healthcare technology firm, has secured significant capital, with its total funding reaching $7M. The company recently announced a major strategic investment of $5M, underscoring its pivotal role in advancing patient management and care coordination solutions. This latest financing round signifies a critical juncture for ViiMed as it aims to further its mission within the dynamic healthcare sector.

What is ViiMed?

ViiMed
SoftwareHealthcare Software

ViiMed operates at the intersection of healthcare and technology, specializing in the development of innovative solutions designed to optimize patient management and enhance care coordination. The company's offerings are engineered to bolster the efficiency of healthcare providers while simultaneously improving patient outcomes. ViiMed's strategic focus is on serving healthcare organizations and professionals who are actively seeking to streamline their operational workflows and elevate the quality of care delivered. Through its commitment to technological advancement, ViiMed endeavors to transform the overall healthcare experience for all stakeholders.

How much funding has ViiMed raised?

ViiMed has raised a total of $7M across 3 funding rounds:

2013

Series A

$1.4M

2014

Private Equity

$650K

2016

Private Equity

$5M

Series A (2013): $1.4M with participation from Wasabi Ventures

Private Equity (2014): $650K, investors not publicly disclosed

Private Equity (2016): $5M, investors not publicly disclosed

Key Investors in ViiMed

Wasabi Ventures

Wasabi Ventures Partners is a venture capital firm that allows accredited investors to invest alongside them in startups. The firm provides partners with access to a platform for monitoring and managing their investment portfolios, along with comprehensive due diligence on each investment opportunity.

What's next for ViiMed?

With the recent influx of major strategic investment, ViiMed is poised for accelerated growth and expansion. This capital infusion is expected to fuel the enhancement of its existing patient management and care coordination technologies, potentially leading to the development of new product lines or features. The company's trajectory suggests a focus on scaling its operations to meet the increasing demand for efficient healthcare solutions. ViiMed's strategic backing indicates a strong market validation and positions it to further solidify its presence and impact within the competitive healthcare technology landscape, likely targeting broader market penetration and deeper integration with healthcare systems.

See full ViiMed company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Content & Collaboration SoftwareSoftwareMobile App Development
Financial SoftwareSoftware
Engineering SoftwareSoftwareBusiness Intelligence (BI) Software
Human Resources SoftwareSoftwareBusiness ServicesSoftware TestingProject Management

Frequently Asked Questions Regarding ViiMed Financial Insights

What are the most recent funding rounds that ViiMed has completed, and what were the funding rounds?
ViiMed has recently completed 3 funding rounds: Private Equity on Feb 3, 2016, Private Equity on Mar 26, 2014, Series A on Jun 3, 2013.
What is the total amount of funding ViiMed has raised to date?
ViiMed has raised a total of $7M in funding to date.
How many funding rounds has ViiMed completed?
ViiMed has completed 3 funding rounds.
How much funding did ViiMed raise in its most recent funding round?
ViiMed raised $5M in its most recent funding round.
Which was the largest funding round in ViiMed's history?
The largest funding round in ViiMed's history was $5M.
See more information about ViiMed